Translate:

Sandy Health Centre

01767 682525

Health Visitors/District Nurses

01767 224100

Field Safety Notice: 25 to 29 November 2019

List of field safety notices (FSNs) from medical device manufacturers from 25 October to 29 November 2019. https://www.gov.uk/drug-device-alerts/field-safety-notice-25-to-29-november-2019?utm_source=e361fa54-3215-4eb1-82f0-0970cbd8c4b3&utm_medium=email&utm_campaign=govuk-notifications&utm_content=immediate  

Alaris™ Gateway Workstation and Alaris™ Gateway Workstation web browser user interface (MDA/2019/040)

Manufactured by Becton Dickinson – if a software security vulnerability is exploited, an attacker with malicious intention could remotely install unauthorised firmware. https://www.gov.uk/drug-device-alerts/alaris-gateway-workstation-and-alaris-gateway-workstation-web-browser-user-interface-mda-2019-040?utm_source=b8820618-ad51-4245-97f4-2ffb7b25dd9e&utm_medium=email&utm_campaign=govuk-notifications&utm_content=immediate  

Field Safety Notice: 18 to 22 November

List of field safety notices (FSNs) from medical device manufacturers from 18 to 22 November 2019. https://www.gov.uk/drug-device-alerts/field-safety-notice-18-to-22-november?utm_source=57571a5a-db00-402b-990f-ff53f3a0ee4d&utm_medium=email&utm_campaign=govuk-notifications&utm_content=immediate  

Class 2 Medicines Recall: Ranitidine Oral Solution 30mg/ml, PL 31862/0023, Ranitidine 150mg Tablets, PL 11311/0138 (EL(19)A/36)

Creo Pharma Limited and Tillomed Laboratories Limited are recalling all unexpired stock of the products listed in this alert. https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-ranitidine-oral-solution-30mg-ml-pl-31862-0023-ranitidine-150mg-tablets-pl-11311-0138-el-19-a-36?utm_source=94f04dab-dfe6-4ab0-bfa1-59a9031468a4&utm_medium=email&utm_campaign=govuk-notifications&utm_content=immediate  

Field Safety Notice: 11 to 15 November

List of field safety notices (FSNs) from medical device manufacturers from 11 to 15 November 2019. https://www.gov.uk/drug-device-alerts/field-safety-notice-11-to-15-november?utm_source=ac4e0b09-e2e6-41a2-b824-3960ad942afb&utm_medium=email&utm_campaign=govuk-notifications&utm_content=immediate  

Field Safety Notice: 04 to 08 November 2019

List of field safety notices (FSNs) from medical device manufacturers from 04 to 08 November 2019 https://www.gov.uk/drug-device-alerts/field-safety-notice-04-to-08-november-2019?utm_source=146667b8-46c8-4a87-bc79-528bd0801111&utm_medium=email&utm_campaign=govuk-notifications&utm_content=immediate  

Field Safety Notice: 28 October to 1 November

List of field safety notices (FSNs) from medical device manufacturers from 28 October to 1 November 2019. https://www.gov.uk/drug-device-alerts/field-safety-notice-28-october-to-1-november?utm_source=aa33a282-0c3a-4403-9d49-a2f73d20a425&utm_medium=email&utm_campaign=govuk-notifications&utm_content=immediate  

Syringe driver pumps: T34™ 3rd edition models only – stop using the pump until updated instructions for use and BodyCommTM V3.0 software are released (MDA/2019/038)

Manufactured by CME (a BD company) – the intended operation of these pumps cannot be verified due to errors in the instructions for use (IFUs) and the incompatibility with older … [continue] Syringe driver pumps: T34™ 3rd edition models only – stop using the pump until updated instructions for use and BodyCommTM V3.0 software are released (MDA/2019/038)

Field Safety Notice: 21 October to 25 October

List of field safety notices (FSNs) from medical device manufacturers from 21 October to 25 October https://www.gov.uk/drug-device-alerts/field-safety-notice-21-october-to-25-october?utm_source=2c976583-23cc-4366-af95-2675aed473ab&utm_medium=email&utm_campaign=govuk-notifications&utm_content=immediate  

Field Safety Notice: 14 October to 18 October

List of field safety notices (FSNs) from medical device manufacturers from 14 October to 18 October https://www.gov.uk/drug-device-alerts/field-safety-notice-14-october-to-18-october?utm_source=f5b450c1-4d08-42ef-9ee9-1c54ab18a4ac&utm_medium=email&utm_campaign=govuk-notifications&utm_content=immediate

Class 4 Medicines Defect Information: Xonvea 10 mg/10 mg gastro-resistant tablets (MDR 025-10/19)

Alliance Pharmaceuticals Ltd has informed the MHRA that there are possible side effects not reported on the Patient Information Leaflet. https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-xonvea-10-mg-10-mg-gastro-resistant-tablets-mdr-025-10-19?utm_source=53c4589f-da0d-47d2-b9d3-656a6f32b705&utm_medium=email&utm_campaign=govuk-notifications&utm_content=immediate

Class 2 Medicines recall: Ranitidine Effervescent Tablets 150mg, Ranitidine Effervescent Tablets 300mg (EL (19)A/27)

Teva UK Limited trading as ratiopharm GmbH is recalling all unexpired stock of Ranitidine Effervescent Tablets from pharmacies. https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-ranitidine-effervescent-tablets-150mg-ranitidine-effervescent-tablets-300mg-el-19-a-27?utm_source=dc70e3f3-ae6c-4e83-a18f-d928dc113d08&utm_medium=email&utm_campaign=govuk-notifications&utm_content=immediate

Translate »